文献速递妇产影像US

晚孕期SGA筛查准确性对不良围产结局的影响及生长轨迹指标的附加价值

Implication of third-trimester screening accuracy for small-for-gestational age and additive value of third-trimester growth-trajectory indicators in predicting severe adverse perinatal outcome in low-risk population: pragmatic secondary analysis of IRIS study.
PubMed 文献 · Ultrasound Obstet Gynecol · 2023-07-05

结果显示,真阳性与假阴性SGA儿的SAPO和产科干预风险均升高,假阳性者与真阴性者无差异;仅ACGV<10%与SAPO中度相关,但EFW<p10联合ACGV<10%并未提高预测效能。结论不支持晚孕期低生长速度作为低风险人群SAPO的附加识别指标。

要点

  • 晚孕期超声怀疑SGA但出生非SGA者,产科干预率与未怀疑SGA者无差异。
  • 真阳性SGA儿SAPO风险aOR 4.46,假阴性SGA儿aOR 2.61,均显著升高。
  • 仅ACGV<10%与SAPO中度相关(aOR 2.15),生长轨迹跨越百分位指标预测效能差。

诊断标准与关键数值

  • SGA真阳性者SAPO的aOR 4.46(95%CI 2.28-8.75),假阴性者aOR 2.61(95%CI 1.74-3.89)。
  • SGA真阳性者引产aOR 2.99(95%CI 2.15-4.17),剖宫产aOR 1.82(95%CI 1.25-2.66),医学指征早产aOR 2.67(95%CI 1.97-3.62)。
  • SGA假阴性者引产aOR 1.38(95%CI 1.14-1.66),剖宫产aOR 1.27(95%CI 1.05-1.54),医学指征早产aOR 1.20(95%CI 1.03-1.40)。
  • ACGV<10%与SAPO的aOR 2.15(95%CI 1.17-3.97);EFW<p10单独aOR 1.95(95%CI 1.13-3.38),联合ACGV<10% aOR 4.69(95%CI 1.99-11.07)。
  • EFW<p10与EFW<p10联合ACGV<10%预测SAPO的AUC分别为0.71(95%CI 0.65-0.76)和0.72(95%CI 0.67-0.77),P=0.51。

临床应用与阅片要点

  • 晚孕期超声怀疑SGA但实际出生体重正常者,无需因筛查假阳性而增加不必要的产科干预。
  • 低风险人群晚孕期评估胎儿生长时,AC或EFW跨越>20百分位、AC跨越>50百分位对异常生长识别价值有限,不宜单独作为报告警示依据。
  • ACGV<10%可作为SAPO风险的辅助提示,但联合EFW<p10并未显著提高预测效能,报告时应结合临床综合判断。

局限性

  • 本研究为随机试验的二次分析,生长轨迹指标仅在亚组(n=7989)中分析。
  • 研究人群为低风险孕妇,结论外推至高风险人群需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To examine the implications of third-trimester small-for-gestational-age (SGA) screening accuracy on severe adverse perinatal outcome (SAPO) and obstetric intervention in a low-risk population. Furthermore, we aimed to explore the additive value of third-trimester sonographic growth-trajectory measurements in predicting SAPO and obstetric intervention.

METHODS: This was a secondary analysis of a Dutch national multicenter stepped-wedge-cluster randomized trial among 11 820 low-risk pregnant women. Using multilevel multivariable logistic regression analysis, we compared SAPO and obstetric interventions in SGA neonates with and without SGA suspected prenatally (true positives and false negatives) and non-SGA neonates with and without SGA suspected prenatally (false positives and true negatives). In a subsample (n = 7989), we analyzed the associations of abdominal circumference (AC) and estimated fetal weight (EFW) < 10th centile (p10) and third-trimester growth-trajectory indicators AC and EFW crossing > 20 and AC crossing > 50 centiles and the lowest decile of AC growth-velocity Z-scores (ACGV < 10%) with SAPO and obstetric interventions.

RESULTS: SGA infants, i.e. the true-positive and false-negative cases, had an increased risk of SAPO (adjusted odds ratio (aOR), 4.46 (95% CI, 2.28-8.75) and aOR 2.61 (95% CI, 1.74-3.89), respectively), and obstetric intervention (aOR for: induction of labor, 2.99 (95% CI, 2.15-4.17) and 1.38 (95% CI, 1.14-1.66); Cesarean section, 1.82 (95% CI, 1.25-2.66) and 1.27 (95% CI, 1.05-1.54); medically indicated preterm delivery, 2.67 (95% CI, 1.97-3.62) and 1.20 (95% CI, 1.03-1.40)). The false-positive cases did not differ from the true negatives for all outcomes, including obstetric intervention. Of the third-trimester growth-trajectory indicators, only ACGV < 10% was associated moderately with SAPO (aOR, 2.15 (95% CI, 1.17-3.97)), while AC and EFW crossing > 20 and AC crossing > 50 centiles were not. Both EFW < p10 alone (aOR, 1.95 (95% CI, 1.13-3.38)) and EFW < p10 combined with ACGV < 10% (aOR, 4.69 (95% CI, 1.99-11.07)) were associated with SAPO, and they performed equally well in predicting SAPO (area under the receiver-operating-characteristics curve, 0.71 (95% CI, 0.65-0.76) vs 0.72 (95% CI, 0.67-0.77), P = 0.51).

CONCLUSION: Neonates who had been suspected falsely of being SGA during pregnancy had no higher rates of obstetric intervention than did those without suspicion of SGA prenatally. Our results do not support that third-trimester low fetal growth velocity (ACGV < 10%) may be of additive value for the identification of fetuses at risk of SAPO in populations remaining at low risk throughout pregnancy. AC and EFW crossing > 20 and AC crossing > 50 centiles performed poorly in identifying abnormal fetal growth. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. van Roekel, Henrichs, Franx, et al. Implication of third-trimester screening accuracy for small-for-gestational age and additive value of third-trimester growth-trajectory indicators in predicting severe adverse perinatal outcome in low-risk population: pragmatic secondary analysis of IRIS study. Ultrasound Obstet Gynecol. 2023. PMID: 36704993. doi:10.1002/uog.26167

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。